These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 8859190)

  • 1. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of genetic instability with immunoreactivities for p53 protein and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Yagi H; Urakami S; Shirakawa H; Ishibe T
    Eur Urol; 1996; 30(1):80-8. PubMed ID: 8854073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
    Br J Urol; 1995 Dec; 76(6):708-13. PubMed ID: 8535713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
    J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological characteristics of inverted papilloma of the urinary bladder.
    Urakami S; Igawa M; Shirakawa H; Shiina H; Ishibe T
    Br J Urol; 1996 Jan; 77(1):55-60. PubMed ID: 8653317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
    Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
    Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry of p53 protein in transitional-cell carcinoma of the bladder using an image analyzer.
    Shiina H; Igawa M; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T
    Oncology; 1996; 53(3):233-40. PubMed ID: 8643227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of immunohistochemically detectable p53 protein in renal cell carcinoma.
    Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T; Kawanishi M
    Eur Urol; 1997; 31(1):73-80. PubMed ID: 9032539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
    Skopelitou A; Hadjiyannakis M; Dimopoulos D; Kamina S; Krikoni O; Alexopoulou V; Rigas C; Agnantis NJ
    Eur Urol; 1997; 31(4):464-71. PubMed ID: 9187909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
    Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
    Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical examinations (Ki67, p53, nm23) and DNA cytophotometry in bladder cancer.
    Krause FS; Feil G; Bichler KH
    Anticancer Res; 2000; 20(6D):5023-8. PubMed ID: 11326661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCNA and p53 in urinary bladder cancer: correlation with histological findings and prognosis.
    Inagaki T; Ebisuno S; Uekado Y; Hirano A; Hiroi A; Shinka T; Ohkawa T
    Int J Urol; 1997 Mar; 4(2):172-7. PubMed ID: 9179692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
    Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of serum testosterone level with proliferating cell nuclear antigen and nm23 protein in human prostatic carcinoma tissue.
    Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Yagi H; Shirakawa R; Nagasaki M
    Oncology; 1997; 54(6):482-9. PubMed ID: 9394845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: positive immunostaining and radiosensitivity.
    Ogura K; Habuchi T; Yamada H; Ogawa O; Yoshida O
    Int J Urol; 1995 Nov; 2(5):302-8. PubMed ID: 8749948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
    Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the cyclin-dependent kinase inhibitor p27 in transitional cell bladder cancers: is it a good predictor for tumor behavior?
    Doganay L; Altaner S; Bilgi S; Kaya E; Ekuklu G; Kutlu K
    Int Urol Nephrol; 2003; 35(2):181-8. PubMed ID: 15072490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis.
    Shiina H; Igawa M; Shigeno K; Yamasaki Y; Urakami S; Yoneda T; Wada Y; Honda S; Nagasaki M
    Oncology; 1999 Apr; 56(3):239-47. PubMed ID: 10202280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of nuclear p53 and tumor progression in bladder cancer.
    Esrig D; Elmajian D; Groshen S; Freeman JA; Stein JP; Chen SC; Nichols PW; Skinner DG; Jones PA; Cote RJ
    N Engl J Med; 1994 Nov; 331(19):1259-64. PubMed ID: 7935683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.